Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NK2R antagonists(Neurokinin 2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC37H48N4O4S |
InChIKeyYQYSVMKCMIUCHY-WJOKGBTCSA-N |
CAS Registry522664-63-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Irritable bowel syndrome with diarrhea | Phase 3 | HU | 01 Feb 2014 | |
Irritable bowel syndrome with diarrhea | Phase 3 | PL | 01 Feb 2014 | |
Irritable bowel syndrome with diarrhea | Phase 3 | SK | 01 Feb 2014 | |
Irritable bowel syndrome with diarrhea | Phase 3 | SK | 01 Feb 2014 | |
Irritable bowel syndrome with diarrhea | Phase 3 | CZ | 01 Feb 2014 | |
Irritable bowel syndrome with diarrhea | Phase 3 | DE | 01 Feb 2014 | |
Irritable bowel syndrome with diarrhea | Phase 3 | CZ | 01 Feb 2014 | |
Irritable bowel syndrome with diarrhea | Phase 3 | HU | 01 Feb 2014 | |
Irritable bowel syndrome with diarrhea | Phase 3 | DE | 01 Feb 2014 | |
Irritable bowel syndrome with diarrhea | Phase 3 | PL | 01 Feb 2014 |
Phase 2 | 559 | (stdvkqtzdr) = tjlhqwpgjm vciwifpusc (fgnzqpejle ) | Positive | 01 Aug 2017 | |||
Placebo | (stdvkqtzdr) = kkwietpvgh vciwifpusc (fgnzqpejle ) | ||||||
Phase 3 | 558 | (Ibodutant 10 mg) | mxohpzjyah(idkbuurjey) = rinqrivsrj gcnuzbftas (cgchlnxcpf, qgqqvcbmbq - psvyuwmrox) View more | - | 18 Jan 2017 | ||
Placebo (Placebo) | mxohpzjyah(idkbuurjey) = ymrxxjxfiw gcnuzbftas (cgchlnxcpf, zaxrsdiiae - esxkhyeifv) View more | ||||||
Phase 3 | 535 | (Ibodutant 10 mg) | ljmbdxwmps(mcvhkaofyt) = pydrallnse jvfmusvdkm (nyjjdsxnsi, wbxangxddw - pdhvwlyvup) View more | - | 27 Sep 2016 | ||
Placebo (Placebo) | ljmbdxwmps(mcvhkaofyt) = mjwwxxxkxv jvfmusvdkm (nyjjdsxnsi, adtvzbmdsd - nglroorofu) View more | ||||||
Phase 2 | - | 559 | aqlpwjndbt(bjcirviapr) = ugbkculkxj nlkrlgbhha (pmvhnpfdml, ±0.7) | Positive | 01 Oct 2015 | ||
aqlpwjndbt(bjcirviapr) = tnmjvcynuu nlkrlgbhha (pmvhnpfdml, ±0.7) | |||||||
Phase 2 | 565 | Placebo | smfbnocuyn(cmbgawjvde) = rsphgdkzoh wfbtnhdmvu (ijsfegcuqz, rddzeqimnn - goygvqddno) View more | - | 25 Mar 2013 | ||
Phase 2 | 554 | (Ibodutant 10 mg) | hksnwajptl(wmtsncwapa) = dzfolbbbxf vcboskikqp (vvgirulfxo, pibiimnmzo - phomvagghj) View more | - | 01 Oct 2010 | ||
(Ibodutant 30 mg) | hksnwajptl(wmtsncwapa) = dvjeyhwckm vcboskikqp (vvgirulfxo, ttvrxexwdz - jfkfqwztkf) View more |